1,0
14 okt 2016
Anonieme werknemer
Voormalige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Size and strength if they figure out what to do with it
Minpunten
Almost everything, since management and the company as a whole, is run so poorly. The FDA is still pounding on Healthcare and RIFTS are common. They haven't released Spect or CT products from the FDA since 2011... yea 2011. The new CT is just a rebranded Brilliance.